论文部分内容阅读
作者为了研究利尿剂对美尼尔氏病的治疗作用,于1980～1985年间对33例美尼尔氏病人应用Dyazide的双盲交叉安慰剂对照研究。Dyazide(50mg三氨喋呤及25mg双氢克尿塞)是一种中等强度的有效利尿剂,可较长期服用而无钾耗竭和低血压的危险。33例中男19,女14,年龄为23～64岁(平均43岁),单耳罹患24例,双耳9例,患者均无利尿剂治疗禁忌症,亦末接受过美尼尔氏病的手术疗法。在42
In order to study the therapeutic effect of diuretics on Meniere’s disease, a double-blind, crossover, placebo-controlled study of Dyazide was administered to 33 Meniere’s patients between 1980 and 1985. Dyazide (50mg triamcinolone and 25mg hydrochlorothiazide) is a moderate-intensity effective diuretic that can be administered over a longer period without the risk of potassium depletion and hypotension. 33 cases of male 19, female 14, aged 23 to 64 years (mean 43 years), 24 cases of single ear, 9 cases of both ears, patients without diuretic treatment of contraindications, nor received Meniere’s disease Surgical treatment. At 42